SEC Form 4 · accession 0001127430-17-000059
INSMED Inc · INSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christine A Pellizzari
Officer — General Counsel & Corp. Sec.
Period of report
May 30, 2017
Accepted (ET)
Jun 1, 2017 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001104506
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 30, 2017 | P | 7,300 | $15.23 | A | 27,300 | D | |
| Common StockF2 | May 31, 2017 | P | 2,700 | $14.89 | A | 30,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.14 to $15.30, inclusive. The reporting person undertakes to provide to Insmed Incorporated, any security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote (2).
- F2The price in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.83 to $14.96, inclusive.